BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23708994)

  • 21. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
    Zhu B; Rohan SM; Lin X
    Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid chromophobe renal cell neoplasm.
    Mai KT; Dhamanaskar P; Belanger E; Stinson WA
    Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma.
    Kowalewski A; Szylberg Ł; Tyloch J; Antosik P; Neska-Długosz I; Frąckowski Ł; Tyloch D; Purpurowicz P; Grzanka D
    Pathol Oncol Res; 2019 Oct; 25(4):1519-1524. PubMed ID: 30467700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
    Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
    Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
    McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
    Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal hybrid oncocytic/chromophobe tumors - a review.
    Hes O; Petersson F; Kuroda N; Hora M; Michal M
    Histol Histopathol; 2013 Oct; 28(10):1257-64. PubMed ID: 23740406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and Molecular Study of Hybrid Oncocytic/Chromophobe Tumor of the Kidney Associated with Sporadic Renal Oncocytosis and Chronic B-Cell Lymphocytic Leukemia: The Possible Contribution of Lymphoma to Renal Oncocytosis.
    Idoate MA; Trigo I; Saenz de Zaitigui J; Pérez-Pérez M; Ríos JJ
    Pathobiology; 2021; 88(4):313-322. PubMed ID: 33882490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
    Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sporadic renal hybrid oncocytic/chromophobe tumor in a young man: A case report.
    Hou B; Liang C
    Medicine (Baltimore); 2019 Aug; 98(33):e16641. PubMed ID: 31415358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.
    Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan CC; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B
    Pathology; 2022 Dec; 54(7):842-847. PubMed ID: 36270849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J; Yang X; Zhou L; Zhang P; Wang C
    Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
    Roncati L; Barbolini G; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
    [No Abstract]   [Full Text] [Related]  

  • 39. FOXI1 Immunohistochemistry Differentiates Benign Renal Oncocytoma from Malignant Chromophobe Renal Cell Carcinoma.
    Molnar A; Horvath CA; Czovek P; Szanto A; Kovacs G
    Anticancer Res; 2019 Jun; 39(6):2785-2790. PubMed ID: 31177114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.